Qube Research & Technologies (QRT)’s Alto Neuroscience ANRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-209,268
Closed -$4.7M 4198
2026
Q1
$4.7M Buy
209,268
+96,476
+86% +$1.79M 0.01% 1687
2025
Q4
$2.01M Buy
+112,792
New +$1.42M ﹤0.01% 2266
2024
Q2
Sell
-4,336
Closed -$66.6K 4863
2024
Q1
$66.6K Buy
+4,336
New +$67.9K ﹤0.01% 3430

Other funds holding ANRO

Qube Research & Technologies (QRT)'s ANRO Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Alto Neuroscience (ANRO) in Q2 2026, closing a stake of 209,268 shares — an estimated $4.7M sold.

Qube Research & Technologies (QRT) first reported a position in ANRO in Q1 2024 and held it in 3 quarters. The position peaked at $4.7M in Q1 2026. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Alto Neuroscience position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 209,268 Alto Neuroscience shares in Q2 2026, an estimated $4.7M.
  • Qube Research & Technologies (QRT) first reported a position in Alto Neuroscience in Q1 2024 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Alto Neuroscience position peaked at $4.7M in Q1 2026.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.